Newman Dignan & Sheerar, Inc. Jazz Pharmaceuticals PLC Transaction History

Newman Dignan & Sheerar, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 07, 2021	SELL	$128.64 - $184.79 $167,231 - $240,227	-1,300 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$150.19 - $173.5 $7,509 - $8,675	50 Added 4.0%	1,300 $214,000
Q4 2020 Jan 29, 2021	BUY	$140.71 - $165.05 $175,887 - $206,312	1,250 New	1,250 $206,000
Q3 2019 Oct 21, 2019	SELL	$125.18 - $143.24 $220,942 - $252,818	-1,765 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$125.55 - $144.48 $221,595 - $255,007	1,765 New	1,765 $252,000

495

57.5M

155K

152K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.1B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Newman Dignan & Sheerar, Inc., based on Form 13F filings with the SEC.

Stay updated on Newman Dignan & Sheerar, Inc. with notifications on news.